Y Intercept (Hong Kong) LTD Regeneron Pharmaceuticals, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $3.83 Billion
- Q3 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 10,318 shares of REGN stock, worth $6.75 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
10,318
Previous 34,874
70.41%
Holding current value
$6.75 Million
Previous $18.3 Million
68.31%
% of portfolio
0.15%
Previous 0.49%
Shares
15 transactions
Others Institutions Holding REGN
# of Institutions
1,437Shares Held
88.9MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$6.16 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.52 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.7 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.16 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.5 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $70.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...